Orchestra BioMed Holdings, Inc. cotiza a 5.72 USD y tiene una capitalización bursátil de $344M. En los últimos 12 meses ha facturado $32M con un margen de flujo de caja libre del -147.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusi…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.37 | $0.26 | $-0.40 |
| Estimado | $-0.40 | $-0.37 | $-0.38 | $-0.43 |
| Sorpresa | — | +0.0% | +168.4% | +7.0% |
| Métrica | OBIO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 99.4% | 57.0% | +42.4% |
| Operating Margin | -154.7% | -38.6% | -116.1% |
| Net Margin | -157.4% | -33.6% | -123.8% |
| FCF Margin | -147.7% | -13.9% | -133.8% |
| ROE | -98.4% | -40.4% | -58.0% |
| ROA | -45.9% | -32.0% | -13.9% |
| Current Ratio | 6.45 | 2.84 | +3.61 |
| Debt / Equity | 0.28 | 0.28 | 0.00 |